FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2091-2098 November 27, 2003 Number 22 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Vokes, E. E. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Weinstein, G. S. PubMed Citation

ABSTRACT

Background Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown.

Methods We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx.

Results A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 percent, P<0.001). The rate of locoregional control was also significantly better with radiotherapy and concurrent cisplatin (78 percent, vs. 61 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 56 percent with radiotherapy alone). Both of the chemotherapy-based regimens suppressed distant metastases and resulted in better disease-free survival than radiotherapy alone. However, overall survival rates were similar in all three groups. The rate of high-grade toxic effects was greater with the chemotherapy-based regimens (81 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 82 percent with radiotherapy with concurrent cisplatin, vs. 61 percent with radiotherapy alone). The mucosal toxicity of concurrent radiotherapy and cisplatin was nearly twice as frequent as the mucosal toxicity of the other two treatments during radiotherapy.

Conclusions In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control.

Source Information

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (A.A.F., D.-J.L.); the University of Texas M.D. Anderson Cancer Center, Houston (H.G., M.M., R.W., W.M., B.G., C.C.); Radiation Therapy Oncology Group Headquarters, Philadelphia (T.F.P.); the H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa (A.T.); Fox Chase Cancer Center, Philadelphia (J.A.R.); the Department of Radiation Oncology, University of Alabama, Birmingham (G.P.); the Department of Veterans Affairs New York Harbor Healthcare System, Brooklyn (A.L.); the Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit (J.E.); and the Department of Radiation Oncology, New York University Medical Center, New York (J.C.).

Address reprint requests to Dr. Forastiere at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans St., Suite G90, Baltimore, MD 21231-1000, or at af{at}jhmi.edu.

Full Text of this Article

This article has been cited by other articles:

• CHEN, Y-H, JIAN, J J-M, CHAN, K-Y, TSAI, S Y, CHENG, S H, YEN, K-C L, CHENG, J C-H (2008). Definitive chemoirradiation for resectable head and neck cancer: treatment outcome and prognostic significance of MRI findings. Br. J. Radiol. 81: 490-498 [Abstract] [Full Text]  
• Knab, B. R., Salama, J. K., Solanki, A., Stenson, K. M., Cohen, E. E., Witt, M. E., Haraf, D. J., Vokes, E. E. (2008). Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Ann Oncol 0: mdn173v1-mdn173 [Abstract] [Full Text]  
• Wang, J., Seethala, R. R., Zhang, Q., Gooding, W., van Waes, C., Hasegawa, H., Ferris, R. L. (2008). Autocrine and Paracrine Chemokine Receptor 7 Activation in Head and Neck Cancer: Implications for Therapy. JNCI J Natl Cancer Inst 100: 502-512 [Abstract] [Full Text]  
• Yang, S.-F., Yang, W.-E., Chang, H.-R., Chu, S.-C., Hsieh, Y.-S. (2008). Luteolin Induces Apoptosis in Oral Squamous Cancer Cells. J. Dent. Res. 87: 401-406 [Abstract] [Full Text]  
• Ong, S. C., Schoder, H., Lee, N. Y., Patel, S. G., Carlson, D., Fury, M., Pfister, D. G., Shah, J. P., Larson, S. M., Kraus, D. H. (2008). Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer. JNM 49: 532-540 [Abstract] [Full Text]  
• Forastiere, A., Weber, R., Ang, K., Trotti, A. III, Pajak, T. F., Ridge, J. A., Saghir, F., Feldman, L. E., Nutting, C. M., Bhide, S. A., Harrington, K. J., Posner, M. R., Haddad, R. I., Tishler, R. B. (2008). Treatment of head and neck cancer.. NEJM 358: 1076-1076 [Full Text]  
• Hutcheson, K. A., Barringer, D. A., Rosenthal, D. I., May, A. H., Roberts, D. B., Lewin, J. S. (2008). Swallowing Outcomes After Radiotherapy for Laryngeal Carcinoma. Arch Otolaryngol Head Neck Surg 134: 178-183 [Abstract] [Full Text]  
• Choong, N., Vokes, E. (2008). Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer. CA Cancer J Clin 58: 32-53 [Abstract] [Full Text]  
• Hinni, M. L., Salassa, J. R., Grant, D. G., Pearson, B. W., Hayden, R. E., Martin, A., Christiansen, H., Haughey, B. H., Nussenbaum, B., Steiner, W. (2007). Transoral Laser Microsurgery for Advanced Laryngeal Cancer. Arch Otolaryngol Head Neck Surg 133: 1198-1204 [Abstract] [Full Text]  
• Chen, A. Y., Halpern, M. (2007). Factors Predictive of Survival in Advanced Laryngeal Cancer. Arch Otolaryngol Head Neck Surg 133: 1270-1276 [Abstract] [Full Text]  
• Patel, R. S., Clark, J., Wyten, R., Gao, K., O'Brien, C. J. (2007). Squamous Cell Carcinoma From an Unknown Head and Neck Primary Site: A "Selective Treatment" Approach. Arch Otolaryngol Head Neck Surg 133: 1282-1287 [Abstract] [Full Text]  
• Glynne-Jones, R., Hoskin, P. (2007). Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?. JCO 25: 5281-5286 [Abstract] [Full Text]  
• Gibcus, J. H., Menkema, L., Mastik, M. F., Hermsen, M. A., de Bock, G. H., van Velthuysen, M.-L. F., Takes, R. P., Kok, K., Alvarez Marcos, C. A., van der Laan, B. F.A.M., van den Brekel, M. W.M., Langendijk, J. A., Kluin, P. M., van der Wal, J. E., Schuuring, E. (2007). Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer. Clin. Cancer Res. 13: 6257-6266 [Abstract] [Full Text]  
• Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., Murphy, B. A., Raez, L. E., Cohen, R. B., Spaulding, M., Tishler, R. B., Roth, B., Viroglio, R. d. C., Venkatesan, V., Romanov, I., Agarwala, S., Harter, K. W., Dugan, M., Cmelak, A., Markoe, A. M., Read, P. W., Steinbrenner, L., Colevas, A. D., Norris, C. M. Jr., Haddad, R. I., the TAX 324 Study Group, (2007). Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer. NEJM 357: 1705-1715 [Abstract] [Full Text]  
• Zenda, S., Onozawa, Y., Tahara, M., Kawashima, M., Shikama, N., Sasaki, S., Boku, N. (2007). Feasibility Study of Single Agent Cisplatin and Concurrent Radiotherapy in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck: Preliminary Results. Jpn J Clin Oncol 0: hym106v1-5 [Abstract] [Full Text]  
• Salama, J. K., Seiwert, T. Y., Vokes, E. E. (2007). Chemoradiotherapy for Locally Advanced Head and Neck Cancer. JCO 25: 4118-4126 [Full Text]  
• Ljumanovic, R., Pouwels, P.J.W., Langendijk, J.A., Knol, D.L., van der Valk, P., Leemans, C.R., Castelijns, J.A. (2007). Has the Degree of Contrast Enhancement with MR Imaging in Laryngeal Carcinoma Added Value to Anatomic Parameters Regarding Prediction of Response to Radiation Therapy?. Am. J. Neuroradiol. 28: 1540-1546 [Abstract] [Full Text]  
• Chen, A. Y., Schrag, N. M., Halpern, M., Stewart, A., Ward, E. M. (2007). Health Insurance and Stage at Diagnosis of Laryngeal Cancer: Does Insurance Type Predict Stage at Diagnosis?. Arch Otolaryngol Head Neck Surg 133: 784-790 [Abstract] [Full Text]  
• Posner, M. (2007). Evolving Strategies for Combined-Modality Therapy for Locally Advanced Head and Neck Cancer. The Oncologist 12: 967-974 [Abstract] [Full Text]  
• Zenda, S., Onozawa, Y., Boku, N., Iida, Y., Ebihara, M., Onitsuka, T. (2007). Single-agent Docetaxel in Patients with Platinum-refractory Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN). Jpn J Clin Oncol 37: 477-481 [Abstract] [Full Text]  
• Kawashima, M., Hayashi, R., Tahara, M., Yamazaki, M., Miyazaki, M., Arahira, S., Ogino, T. (2007). Accelerated Radiotherapy and Larynx Preservation in Favorable-risk Patients with T2 or Worse Hypopharyngeal Cancer. Jpn J Clin Oncol 0: hym040v1-8 [Abstract] [Full Text]  
• Allen, A. M., Tishler, R. B. (2007). Commentary: IMRT for Head and Neck Cancer: Many Chapters Left to Write. The Oncologist 12: 565-568 [Abstract] [Full Text]  
• Hoshitani, Y., Ishida, H., Otsuki, N., Shirakawa, T., Gotoh, A., Nibu, K.-i. (2007). Induction of Immunological Antitumor Effects by Adenovirus-Mediated Gene Transfer of B7-1 in a Murine Squamous Cell Carcinoma Cell Line. Arch Otolaryngol Head Neck Surg 133: 270-275 [Abstract] [Full Text]  
• Konski, A. A., Pajak, T. F., Movsas, B., Coyne, J., Harris, J., Gwede, C., Garden, A., Spencer, S., Jones, C., Watkins-Bruner, D. (2006). Disadvantage of Men Living Alone Participating in Radiation Therapy Oncology Group Head and Neck Trials. JCO 24: 4177-4183 [Abstract] [Full Text]  
• Mendenhall, W. M., Hinerman, R. W., Amdur, R. J., Malyapa, R. S., Lansford, C. D., Werning, J. W., Villaret, D. B. (2006). Postoperative radiotherapy for squamous cell carcinoma of the head and neck.. Clin Med Res 4: 200-208 [Abstract] [Full Text]  
• Pfister, D. G., Laurie, S. A., Weinstein, G. S., Mendenhall, W. M., Adelstein, D. J., Ang, K. K., Clayman, G. L., Fisher, S. G., Forastiere, A. A., Harrison, L. B., Lefebvre, J.-L., Leupold, N., List, M. A., O'Malley, B. O., Patel, S., Posner, M. R., Schwartz, M. A., Wolf, G. T. (2006). American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. JCO 24: 3693-3704 [Abstract] [Full Text]  
• Cohen, E. E.W., Haraf, D. J., List, M. A., Kocherginsky, M., Mittal, B. B., Rosen, F., Brockstein, B., Williams, R., Witt, M. E., Stenson, K. M., Kies, M. S., Vokes, E. E. (2006). High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial. JCO 24: 3438-3444 [Abstract] [Full Text]  
• Forastiere, A. A., Trotti, A., Pfister, D. G., Grandis, J. R. (2006). Head and Neck Cancer: Recent Advances and New Standards of Care. JCO 24: 2603-2605 [Full Text]  
• Brizel, D. M., Esclamado, R. (2006). Concurrent Chemoradiotherapy for Locally Advanced, Nonmetastatic, Squamous Carcinoma of the Head and Neck: Consensus, Controversy, and Conundrum. JCO 24: 2612-2617 [Abstract] [Full Text]  
• Adelstein, D. J., LeBlanc, M. (2006). Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?. JCO 24: 2624-2628 [Abstract] [Full Text]  
• Rosenthal, D. I., Lewin, J. S., Eisbruch, A. (2006). Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer. JCO 24: 2636-2643 [Abstract] [Full Text]  
• Wong, S. J., Machtay, M., Li, Y. (2006). Locally Recurrent, Previously Irradiated Head and Neck Cancer: Concurrent Re-Irradiation and Chemotherapy, or Chemotherapy Alone?. JCO 24: 2653-2658 [Abstract] [Full Text]  
• Haddad, R., Tishler, R., Wirth, L., Norris, C. M., Goguen, L., Sullivan, C., O'Donnell, L., Li, Y., Posner, M. (2006). Rate of pathologic complete responses to docetaxel, Cisplatin, and Fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.. Arch Otolaryngol Head Neck Surg 132: 678-681 [Abstract] [Full Text]  
• Lu, S.-L., Herrington, H., Reh, D., Weber, S., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., Andersen, P., Corless, C. L., Wang, X.-J. (2006). Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.. Genes Dev. 20: 1331-1342 [Abstract] [Full Text]  
• Goguen, L. A., Posner, M. R., Tishler, R. B., Wirth, L. J., Norris, C. M., Annino, D. J., Sullivan, C. A., Li, Y., Haddad, R. I. (2006). Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.. Arch Otolaryngol Head Neck Surg 132: 526-531 [Abstract] [Full Text]  
• Gelbard, A., Garnett, C. T., Abrams, S. I., Patel, V., Gutkind, J. S., Palena, C., Tsang, K.-Y., Schlom, J., Hodge, J. W. (2006). Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis.. Clin. Cancer Res. 12: 1897-1905 [Abstract] [Full Text]  
• Alho, O.-P., Teppo, H., Mantyselka, P., Kantola, S. (2006). Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases.. CMAJ 174: 779-784 [Abstract] [Full Text]  
• Adelstein, D. J., Saxton, J. P., Rybicki, L. A., Esclamado, R. M., Wood, B. G., Strome, M., Lavertu, P., Lorenz, R. R., Carroll, M. A. (2006). Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution. JCO 24: 1064-1071 [Abstract] [Full Text]  
• Urba, S., Wolf, G., Eisbruch, A., Worden, F., Lee, J., Bradford, C., Teknos, T., Chepeha, D., Prince, M., Hogikyan, N., Taylor, J. (2006). Single-Cycle Induction Chemotherapy Selects Patients With Advanced Laryngeal Cancer for Combined Chemoradiation: A New Treatment Paradigm. JCO 24: 593-598 [Abstract] [Full Text]  
• Pfister, D. G., Ridge, J. A. (2006). Induction Chemotherapy for Larynx Preservation: Patient Selection or Therapeutic Effect?. JCO 24: 540-543 [Full Text]  
• Yang, M.-H., Chiang, W.-C., Chou, T.-Y., Chang, S.-Y., Chen, P.-M., Teng, S.-C., Wu, K.-J. (2006). Increased NBS1 Expression Is a Marker of Aggressive Head and Neck Cancer and Overexpression of NBS1 Contributes to Transformation. Clin. Cancer Res. 12: 507-515 [Abstract] [Full Text]  
• Adelstein, D. J. (2005). Induction Redux: Once More With Taxanes. JCO 23: 8556-8558 [Full Text]  
• Hitt, R., Lopez-Pousa, A., Martinez-Trufero, J., Escrig, V., Carles, J., Rizo, A., Isla, D., Vega, M. E., Marti, J. L., Lobo, F., Pastor, P., Valenti, V., Belon, J., Sanchez, M. A., Chaib, C., Pallares, C., Anton, A., Cervantes, A., Paz-Ares, L., Cortes-Funes, H. (2005). Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer. JCO 23: 8636-8645 [Abstract] [Full Text]  
• Rastogi, M., Srivastava, M., Chufal, K. S., Pant, M. C., Srivastava, K., Bhatt, M. B. (2005). Mitomycin and Fluorouracil in Combination with Concomitant Radiotherapy: A Potentially Curable Approach for Locally Advanced Head and Neck Squamous Cell Carcinoma. Jpn J Clin Oncol 35: 572-579 [Abstract] [Full Text]  
• El-Deiry, M., Funk, G. F., Nalwa, S., Karnell, L. H., Smith, R. B., Buatti, J. M., Hoffman, H. T., Clamon, G. H., Graham, S. M., Trask, D. K., Dornfeld, K. J., Yao, M. (2005). Long-term Quality of Life for Surgical and Nonsurgical Treatment of Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 131: 879-885 [Abstract] [Full Text]  
• Posner, M. R. (2005). Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy. The Oncologist 10: 11-19 [Abstract] [Full Text]  
• Wee, J., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., Tan, H. S. K., Lee, K. S., Loong, S., Sethi, V., Chua, E. J., Machin, D. (2005). Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety. JCO 23: 6730-6738 [Abstract] [Full Text]  
• Enepekides, D. J. (2005). Concurrent Chemoradiotherapy as the Most Appropriate Treatment for Most T3 Laryngeal Carcinomas. Arch Otolaryngol Head Neck Surg 131: 815-818 [Full Text]  
• Smith, R. B. (2005). Concurrent Chemoradiation as a Treatment Option for Advanced-Stage Laryngeal Cancers. Arch Otolaryngol Head Neck Surg 131: 820-820 [Full Text]  
• Johnson, J. T. (2005). American Head and Neck Society Presidential Address: Head and Neck Surgery in a New Era of Therapeutic Potential. Arch Otolaryngol Head Neck Surg 131: 549-550 [Full Text]  
• Gillespie, M. B., Brodsky, M. B., Day, T. A., Sharma, A. K., Lee, F.-s., Martin-Harris, B. (2005). Laryngeal Penetration and Aspiration During Swallowing After the Treatment of Advanced Oropharyngeal Cancer. Arch Otolaryngol Head Neck Surg 131: 615-619 [Abstract] [Full Text]  
• Yin, X., Zhang, H., Burrows, F., Zhang, L., Shores, C. G. (2005). Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor against Head and Neck Squamous Cell Carcinoma In vitro and In vivo. Clin. Cancer Res. 11: 3889-3896 [Abstract] [Full Text]  
• Ang, K. K., Harris, J., Garden, A. S., Trotti, A., Jones, C. U., Carrascosa, L., Cheng, J. D., Spencer, S. S., Forastiere, A., Weber, R. S. (2005). Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14. JCO 23: 3008-3015 [Abstract] [Full Text]  
• Roh, J.-L., Kim, A.-Y., Cho, M. J. (2005). Xerostomia Following Radiotherapy of the Head and Neck Affects Vocal Function. JCO 23: 3016-3023 [Abstract] [Full Text]  
• Bucci, M. K., Bevan, A., Roach, M. III (2005). Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond. CA Cancer J Clin 55: 117-134 [Abstract] [Full Text]  
• Posner, M. R. (2005). Adjuvant Post-Operative Chemoradiotherapy In Head and Neck Cancer: A Standard Of Care?. The Oncologist 10: 174-175 [Full Text]  
• Garden, A. S. (2005). Is There Still a Role for Induction Chemotherapy for Head and Neck Cancer?. JCO 23: 1059-1060 [Full Text]  
• Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., Lamb, D., McClure, B. (2005). Tirapazamine, Cisplatin, and Radiation Versus Fluorouracil, Cisplatin, and Radiation in Patients With Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). JCO 23: 79-87 [Abstract] [Full Text]  
• Urba, S. G., Moon, J., Giri, P.G. S., Adelstein, D. J., Hanna, E., Yoo, G. H., LeBlanc, M., Ensley, J. F., Schuller, D. E. (2005). Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial. JCO 23: 88-95 [Abstract] [Full Text]  
• Lefebvre, J.-L. (2005). Current clinical outcomes demand new treatment options for SCCHN. Ann Oncol 16: vi7-vi12 [Abstract] [Full Text]  
• Ang, K. K. (2004). Concurrent Radiation Chemotherapy for Locally Advanced Head and Neck Carcinoma: Are We Addressing Burning Subjects?. JCO 22: 4657-4659 [Full Text]  
• Forastiere, A. A. (2004). Is There a New Role for Induction Chemotherapy in the Treatment of Head and Neck Cancer?. JNCI J Natl Cancer Inst 96: 1647-1649 [Full Text]  
• Zorat, P. L., Paccagnella, A., Cavaniglia, G., Loreggian, L., Gava, A., Mione, C. A., Boldrin, F., Marchiori, C., Lunghi, F., Fede, A., Bordin, A., Da Mosto, M. C., Sileni, V. C., Orlando, A., Jirillo, A., Tomio, L., Pappagallo, G. L., Ghi, M. G. (2004). Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up. JNCI J Natl Cancer Inst 96: 1714-1717 [Abstract] [Full Text]  
• Dufour, X., Hans, S., De Mones, E., Brasnu, D., Menard, M., Laccourreye, O. (2004). Local Control After Supracricoid Partial Laryngectomy for "Advanced" Endolaryngeal Squamous Cell Carcinoma Classified as T3. Arch Otolaryngol Head Neck Surg 130: 1092-1099 [Abstract] [Full Text]  
• Psyrri, A., Kwong, M., DiStasio, S., Lekakis, L., Kassar, M., Sasaki, C., Wilson, L.D., Haffty, B.G., Son, Y.H., Ross, D.A., Weinberger, P.M., Chung, G.G., Zelterman, D., Burtness, B.A., Cooper, D.L. (2004). Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up. JCO 22: 3061-3069 [Abstract] [Full Text]  
• Brockstein, B., Haraf, D. J., Rademaker, A. W., Kies, M. S., Stenson, K. M., Rosen, F., Mittal, B. B., Pelzer, H., Fung, B. B., Witt, M.-E., Wenig, B., Portugal, L., Weichselbaum, R. W., Vokes, E. E. (2004). Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15: 1179-1186 [Abstract] [Full Text]  
• Milano, M. T., Haraf, D. J., Stenson, K. M., Witt, M. E., Eng, C., Mittal, B. B., Argiris, A., Pelzer, H., Kozloff, M. F., Vokes, E. E. (2004). Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck. Clin. Cancer Res. 10: 4922-4932 [Abstract] [Full Text]  
• Garden, A.S., Harris, J., Vokes, E.E., Forastiere, A.A., Ridge, J.A., Jones, C., Horwitz, E.M., Glisson, B.S., Nabell, L., Cooper, J.S., Demas, W., Gore, E. (2004). Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck. JCO 22: 2856-2864 [Abstract] [Full Text]  
• Hanna, E., Alexiou, M., Morgan, J., Badley, J., Maddox, A. M., Penagaricano, J., Fan, C.-Y., Breau, R., Suen, J. (2004). Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients With Advanced Cancer of the Head and Neck: Efficacy, Toxic Effects, and Limitations. Arch Otolaryngol Head Neck Surg 130: 861-867 [Abstract] [Full Text]  
• Hanna, E., Sherman, A., Cash, D., Adams, D., Vural, E., Fan, C.-Y., Suen, J. Y. (2004). Quality of Life for Patients Following Total Laryngectomy vs Chemoradiation for Laryngeal Preservation. Arch Otolaryngol Head Neck Surg 130: 875-879 [Abstract] [Full Text]  
• Cooper, J. S., Pajak, T. F., Forastiere, A. A., Jacobs, J., Campbell, B. H., Saxman, S. B., Kish, J. A., Kim, H. E., Cmelak, A. J., Rotman, M., Machtay, M., Ensley, J. F., Chao, K.S. C., Schultz, C. J., Lee, N., Fu, K. K., the Radiation Therapy Oncology Group 9501/Intergro, (2004). Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. NEJM 350: 1937-1944 [Abstract] [Full Text]  
• Cohen, E. E.W., Lingen, M. W., Vokes, E. E. (2004). The Expanding Role of Systemic Therapy in Head and Neck Cancer. JCO 22: 1743-1752 [Abstract] [Full Text]  
• Weinstein, G. S., Myers, E. N., Shapshay, S. M., Colvett, K. T., Gupta, T., Agarwal, J., Lashkar, S. G., Langer, M., Guntinas-Lichius, O., Haddad, R. I., Tishler, R. B., Posner, M. R., Forastiere, A. A., Pajak, T. F., Maor, M., Weber, R. (2004). Nonsurgical Treatment of Laryngeal Cancer. NEJM 350: 1049-1053 [Full Text]